Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mobile Health for Tobacco Cessation in Lao Cancer Survivors
NCT05253573Phase 2Completed
- Sponsor
- University of Oklahoma
- Start
- Apr 2022
- Primary completion
- Aug 2023
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by University of Oklahoma. Primary endpoint: Biochemically Verified 7-day Point Prevalence Abstinence at 3 months. Started Apr 2022; status: completed.
Beyond the preview
Go deeper on NCT05253573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05253573.